Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
AIDS
vaccine effects may wear off, researchers say 3:32 AM 2/19/2010
Reuters
The AIDS vaccine that appeared to work in Thailand may only temporarily
protect patients for a year.
...
FDA
calls for limits on asthma drugs 12:10 AM 2/19/2010
Los Angeles Times
The US FDA urged physicians to switch asthma patients away from medicines
containing both long-acting beta agonists (LABAs) and inhaled corticosteroids.
...
US
approves Roche's Rituxan cancer drug for CLL 4:30 PM 2/18/2010
Reuters
The US FDA approved Roche's blockbuster cancer drug Rituxan to treat the
most common form of leukemia in adults, chronic lymphocytic leukemia (CLL).
...
Regeneron,
Bayer say eye drug meets mid-stage goal 10:30 AM 2/18/2010
Reuters
Regeneron Pharmaceuticals and the Bayer HealthCare unit of Germany's
Bayer said their experimental drug VEGF Trap-Eye to treat diabetic macular edema met its primary goal in a
mid-stage study.
...
German
case tests patent on top Glaxo drug Advair 9:39 AM 2/18/2010
Reuters
GlaxoSmithKline will defend a key patent next week on its top drug in
Germany in a court case highlighting the worldwide generic threat to lung treatment Advair.
...
US
denies approval of Xenoport, Glaxo RLS drug 5:14 AM 2/18/2010
Reuters
The US FDA denied approval for the drug Horizant from XenoPort and
GlaxoSmithKline to treat restless legs syndrome because of a potential link to cancer found in rats.
...
Government
probes potential risks of cancer, flu, MS drugs 4:34 AM 2/18/2010
Reuters
The US FDA is probing reports of hearing loss with Novartis cancer drug
Gleevec, hypothermia with Roche's flu drug Tamiflu, and pericarditis with Biogen Idec and Elan Corp's multiple
sclerosis drug Tysabri.
...
HIV
drugs prevent infection in African study 2:22 AM 2/18/2010
Reuters
People across Africa who took AIDS drugs were far less likely to infect
their partners with the virus.
...
Novartis
VC arm backs universal flu shot company 6:02 AM 2/17/2010
Reuters
Immune Targeting Systems received funding from a group of investors including the
venture capital arm of Novartis to progress its lead candidate FP-01 through to completion of Phase II proof of
concept studies.
...
Discovery:
Only animal trials needed for lung drug OK 7:57 AM 2/16/2010
Reuters
Discovery Laboratories Inc will conduct additional preclinical studies to
gain approval for its drug Surfaxin to treat respiratory illness in infants instead of the limited clinical
trial to assess the pharmacodynamic response in preterm infants with respiratory distress syndrome (RDS).
...
Rigel
in pact with AstraZeneca for arthritis drug 4:55 AM 2/16/2010
Reuters
AstraZeneca wades into the rheumatoid arthritis market signing a deal for
rights to Rigel Pharmaceuticals Inc's next-generation drug R788 (fostamatinib disodium) which failed one
mid-stage Phase II study.
...
Diabetes
drug stinks, doctors find 6:29 PM 2/15/2010
Reuters
Metformin smells like fish or dirty socks which can make people nauseated. Coating the
pills may solve the problem.
...
Herpes
Drug Might Also Slow HIV Progression 12:08 PM 2/15/2010
BusinessWeek
People infected with both the HIV-1 strain of the AIDS virus and herpes simplex
virus type 2 could benefit from acyclovir.
...
Shionogi
seeks OK for influenza drug for children 6:29 AM 2/15/2010
Reuters
Shionogi & Co has applied for regulatory approval in Japan to make and
sell its intravenous influenza drug Rapiacta (peramivir) to treat children.
...
<- Day Earlier | Today's News
|
